Authors : Ilyas M.; Fauzi Muh; Martini

Volume/Issue : Volume 10 - 2025, Issue 10 - October

Google Scholar : https://tinyurl.com/zmbn2ymp

Scribd : https://tinyurl.com/4jrh2xm5

DOI : https://doi.org/10.38124/ijisrt/25oct222

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Asymptomatic malaria remains a hidden barrier to elimination efforts in Southeast Asia. Individuals without symptoms often serve as undetected reservoirs of infection, making them difficult to capture through symptom-based surveillance. Understanding prevalence, species distribution, at-risk populations, and diagnostic approaches is essential to inform evidence-based interventions. The reported prevalence of asymptomatic malaria ranged from 1.03% to 88.6%, with the highest found in Southern Papua. Molecular methods such as PCR, qPCR, nested PCR and HVUSqPCR known for higher sensitivity, detected submicroscopic infections and reported prevalence up to 80% compared with RDTs and Microscopy. Among species, P. vivax showed the highest prevalence at 81%, followed by P. knowlesi, P. falciparum, P. ovale, P. cynomolgi, and P. malariae. High-risk groups is in border areas, forests, or highly mobile communities. The findings emphasize the need for active surveillance, sensitive diagnostics, and targeted interventions to address asymptomatic reservoirs and support evidence-informed elimination strategies in Southeast Asia.

Keywords : Malaria Asymptomatic, Prevalence, Southeast Asia, Plasmodium Spp.

References :

1. WHO, World malaria World malaria report report. 2023. [Online]. Available: https://www.wipo.int/amc/en/mediation/%0Ahttps://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023
2. M. Imwong et al., “The epidemiology of subclinical malaria infections in South-East Asia: Findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam,” Malar. J., vol. 14, no. 1, Sep. 2015, doi: 10.1186/s12936-015-0906-x.
3. S. Hoyer et al., “Focused Screening and Treatment (FSAT): A PCR-Based Strategy to Detect Malaria Parasite Carriers and Contain Drug Resistant P. falciparum, Pailin, Cambodia,” PLoS One, vol. 7, no. 10, 2012, doi: 10.1371/journal.pone.0045797.
4. M. Kotepui, K. U. Kotepui, F. R. Masangkay, A. Mahittikorn, and P. Wilairatana, “Prevalence and proportion estimate of asymptomatic Plasmodium infection in Asia: a systematic review and meta-analysis,” Sci. Rep., vol. 13, no. 1, 2023, doi: 10.1038/s41598-023-37439-9.
5. T. Bousema, L. Okell, I. Felger, and C. Drakeley, “Asymptomatic malaria infections: Detectability, transmissibility and public health relevance,” Nat. Rev. Microbiol., vol. 12, no. 12, pp. 833–840, 2014, doi: 10.1038/nrmicro3364.
6. C. Whittaker et al., “Global patterns of submicroscopic Plasmodium falciparum malaria infection: insights from a systematic review and meta-analysis of population surveys,” The Lancet Microbe, vol. 2, no. 8, pp. e366–e374, 2021, doi: 10.1016/S2666-5247(21)00055-0.
7. K. Phommasone et al., “Asymptomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos),” Malar. J., vol. 15, no. 1, 2016, doi: 10.1186/s12936-016-1336-0.
8. I. Istiana, U. Hadi, Y. P. Dachlan, and H. Arwati, “Malaria at Forest Areas in South Kalimantan, Indonesia: Risk Factors and Strategies for Elimination,” Open Access Maced. J. Med. Sci., vol. 9, no. E SE-Public Health Epidemiology, pp. 1147–1154, Oct. 2021, doi: 10.3889/oamjms.2021.7012.
9. M. Gruenberg et al., “Utility of ultra-sensitive qPCR to detect Plasmodium falciparum and Plasmodium vivax infections under different transmission intensities,” Malar. J., vol. 19, no. 1, 2020, doi: 10.1186/s12936-020-03374-7.
10. X. Chen et al., “Loop-mediated isothermal amplification (LAMP) assays targeting 18S ribosomal RNA genes for identifying P. vivax and P. ovale species and mitochondrial DNA for detecting the genus Plasmodium,” Parasites and Vectors, vol. 14, no. 1, pp. 1–10, 2021, doi: 10.1186/s13071-021-04764-9.
11. K. M. Fornace et al., “Exposure and infection to Plasmodium knowlesi in case study communities in Northern Sabah, Malaysia and Palawan, The Philippines,” PLoS Negl. Trop. Dis., vol. 12, no. 6, 2018, doi: 10.1371/journal.pntd.0006432.
12. M. T. Zaw et al., “Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar,” Malar. J., vol. 16, no. 1, 2017, doi: 10.1186/s12936-017-1789-9.
13. H. Arksey and L. and O’Malley, “Scoping studies: towards a methodological framework,” Int. J. Soc. Res. Methodol., vol. 8, no. 1, pp. 19–32, Feb. 2005, doi: 10.1080/1364557032000119616.
14. A. C. Tricco et al., “PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.,” Ann. Intern. Med., vol. 169, no. 7, pp. 467–473, Oct. 2018, doi: 10.7326/M18-0850.
15. Z. Pava et al., “Submicroscopic and asymptomatic plasmodium parasitaemia associated with significant risk of anaemia in Papua, Indonesia,” PLoS One, vol. 11, no. 10, pp. 1–17, Oct. 2016, doi: 10.1371/journal.pone.0165340.
16. T. Bouwe et al., “Asymptomatic malaria infections and associated risk factors in malaria-eliminating settings of Nong District, Savannakhet Province, Lao People’s Democratic Republic,” Trop. Med. Health, vol. 53, no. 1, p. 24, Feb. 2025, doi: 10.1186/s41182-025-00702-y.
17. N. R. Noordin et al., “Prevalence of asymptomatic and/or low-density malaria infection among high-risk groups in peninsular malaysia,” Am. J. Trop. Med. Hyg., vol. 103, no. 3, pp. 1107–1110, 2020, doi: 10.4269/ajtmh.20-0268.
18. D. Doum et al., “An active and targeted survey reveals asymptomatic malaria infections among high-risk populations in Mondulkiri, Cambodia,” Malar. J., vol. 22, no. 1, p. 193, Dec. 2023, doi: 10.1186/s12936-023-04630-2.
19. N. N. San et al., “Cross-sectional study of asymptomatic malaria and seroepidemiological surveillance of seven districts in Gia Lai province, Vietnam,” Malar. J., vol. 21, no. 1, 2022, doi: 10.1186/s12936-022-04060-6.
20. D. J. Cooper et al., “Plasmodium knowlesi Malaria in Sabah, Malaysia, 2015-2017: Ongoing Increase in  Incidence Despite Near-elimination of the Human-only Plasmodium Species.,” Clin. Infect. Dis.  an Off. Publ. Infect. Dis.  Soc. Am., vol. 70, no. 3, pp. 361–367, Jan. 2020, doi: 10.1093/cid/ciz237.
21. K. M. Fornace et al., “Asymptomatic and Submicroscopic Carriage of Plasmodium knowlesi Malaria in  Household and Community Members of Clinical Cases in Sabah, Malaysia.,” J. Infect. Dis., vol. 213, no. 5, pp. 784–787, Mar. 2016, doi: 10.1093/infdis/jiv475.
22. S. Shimizu et al., “Malaria cross-sectional surveys identified asymptomatic infections of Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi in Surat Thani, a southern province of Thailand,” Int. J. Infect. Dis., vol. 96, pp. 445–451, 2020, doi: 10.1016/j.ijid.2020.05.022.
23. H. H. Quang et al., “Cross-sectional survey of asymptomatic malaria in Dak Nong province in the Central Highlands of Vietnam for the malaria elimination roadmap,” PLoS One, vol. 16, no. 10 October 2021, 2021, doi: 10.1371/journal.pone.0258580.
24. S. Opoku Afriyie et al., “Accuracy of diagnosis among clinical malaria patients: comparing microscopy, RDT and a highly sensitive quantitative PCR looking at the implications for submicroscopic infections,” Malar. J., vol. 22, no. 1, pp. 1–11, 2023, doi: 10.1186/s12936-023-04506-5.
25. B. Singh and C. Daneshvar, “Human infections and detection of Plasmodium knowlesi.,” Clin. Microbiol. Rev., vol. 26, no. 2, pp. 165–184, Apr. 2013, doi: 10.1128/CMR.00079-12.